CP
EW icon

CenterBook Partners’s Edwards Lifesciences EW Stock Holding History

CenterBook Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-45,386
Closed -$3.14M – 422
2023
Q3 		$3.14M Buy
45,386
+25,157
+124% +$2.02M 0.39% 77
2023
Q2 		$1.91M Buy
20,229
+4,198
+26% +$365K 0.24% 150
2023
Q1 		$1.33M Buy
+16,031
New +$1.26M 0.19% 175

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

CenterBook Partners's EW Position: Q4 2023 in Review

CenterBook Partners sold out of Edwards Lifesciences (EW) in Q4 2023, closing a stake of 45,386 shares — an estimated $3.14M sold.

CenterBook Partners first reported a position in EW in Q1 2023 and held it in 3 quarters. The position peaked at $3.14M in Q3 2023. 1,245 funds tracked by Wall St. Rank hold EW as of Q4 2023.

  • CenterBook Partners reported no remaining Edwards Lifesciences position as of Q4 2023 after selling out during the quarter.
  • CenterBook Partners sold 45,386 Edwards Lifesciences shares in Q4 2023, an estimated $3.14M.
  • CenterBook Partners first reported a position in Edwards Lifesciences in Q1 2023 and held it in 3 quarters.
  • CenterBook Partners's Edwards Lifesciences position peaked at $3.14M in Q3 2023.
  • 1,245 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2023.

Based on CenterBook Partners's 13F filing for Q4 2023, filed 13 Feb 2024.